Denna sida på svenska
Loading profile information...


PhD, Karolinska Institutet

MD, Uppsala University


Research description

Selected publications

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Askling J, van Vollenhoven R, Granath F, Raaschou P, Fored C, Baecklund E, et al
Arthritis Rheum. 2009 Nov;60(11):3180-9

Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
Holmqvist M, Neovius M, Eriksson J, Mantel , WÃ¥llberg-Jonsson S, Jacobsson L, et al
JAMA 2012 Oct;308(13):1350-6

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
Raaschou P, Simard J, Holmqvist M, Askling J,
BMJ 2013 Apr;346():f1939

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
Ljung L, Simard J, Jacobsson L, Rantapää-Dahlqvist S, Askling J,
Arthritis Rheum. 2012 Jan;64(1):42-52

Swedish registers to examine drug safety and clinical issues in RA.
Askling J, Fored C, Geborek P, Jacobsson L, van Vollenhoven R, Feltelius N, et al
Ann. Rheum. Dis. 2006 Jun;65(6):707-12






Loading publication list...